FDA Commissioner Marty Makary Resigns, Ending a Controversial Tenure at the Agency

Chronological Source Flow
Back

AI Fusion Summary

Marty Makary resigns as FDA commissioner after an uneven tenure, following a 2025 Oval Office deal with Pfizer to lower Medicaid drug prices announced by President Trump and CEO Albert Bourla.
Community Comments
Loading updates...
0